• Home/
  • 2013/
  • 10/
  • New Listings For The PBS Announced

PBS News

New listings for the PBS announced on 28 October 2013

28 October 2013

New and amended listings for the PBS have been announced. More information is available on the Minister for Health's website.

 

New and amended listings for the PBS

  • alogliptin (Nesina®) - for the treatment of type 2 diabetes
  • botulinum toxin type A (Botox®) - for the treatment of chronic migraine
  • budesonide (Budenofalk®) - for the treatment of ulcerative colitis
  • budesonide with eformoterol (Symbicort Rapihaler®) - for the treatment of chronic obstructive pulmonary disease and asthma
  • canagliflozin (Invokana®) - for the treatment of type 2 diabetes
  • dabrafenib (Tafinlar®) - for the treatment of malignant melanoma
  • dapagliflozin (Forxiga®) - for the treatment of type 2 diabetes
  • denosumab (Prolia®) - for the treatment of osteoporosis
  • dimethyl fumarate (Tecfidera®) - for the treatment of multiple sclerosis
  • everolimus (Afinitor®) - for the treatment of tuberous sclerosis
  • ezetimibe with atorvastatin (Atozet®) - for the treatment of high cholesterol
  • fluticasone with eformoterol (Flutiform®) - for the treatment of asthma
  • ivabradine (Coralan®) - for the treatment of chronic heart failure
  • ivermectin (Stromectol®) - for the treatment of strongyloidiasis
  • nicotine replacement therapy (Nicotinell Step 1®, Nicotinell Step 2®, Nicotinell Step 3®, Nicorette Patch®, Nicabate P®) - for use in smoking cessation
  • olmesartan with amlodipine and hydrochlorothiazide (Sevikar HCT®) - for the treatment of hypertension
  • rifaximin (Xifaxan®) - for the treatment of hepatic encephalopathy
  • strontium ranelate (Protos 2 g®) - for the treatment of osteoporosis
  • sunitinib (Sutent®) - for the treatment of pancreatic neuroendocrine tumour
  • teriflunomide (Aubagio®) - for the treatment of multiple sclerosis

Two co‑dependent technology items will also be listed on the Medicare Benefits Schedule to support the PBS listing for dabrafenib and botulinum toxin type A.

Price changes to existing PBS‑listed medicines

  • aurothiomalate sodium (Myocrisin®) - for the treatment of rheumatoid arthritis
  • azithromycin (Zithromax®) - for the treatment of Mycobacterium avium complex infection
  • ethosuximide (Zarontin®) - for the treatment of epilepsy
  • insulin bovine (Hypurin Neutral®, Hypurin Isophane®) - for the treatment of diabetes
  • nitrazepam (Alodorm®) - for the treatment of insomnia and epilepsy
  • phenytoin (Dilantin®, Dilantin Infatabs®) - for the treatment of epilepsy
  • rifabutin (Mycobutin®) - for the treatment of Mycobacterium avium complex infection
  • vigabatrin (Sabril®) - for the treatment of epilepsy

Minor and administrative changes

  • amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides (Alfamino®) - for infants and children with allergy to cows’ milk
  • darunavir (Prezista®) - for the treatment of HIV infection
  • milk powder lactose free formula predigested (Karicare Aptamil Gold De-Lact®) - for lactose intolerance in infants
  • terbutaline (Bricanyl Turbuhaler®) - for the treatment of chronic obstructive pulmonary disease and asthma
  • whey protein formula supplemented with amino acids, long chain polyunsaturated fatty acids, vitamins and minerals, low in protein, phosphate, potassium and lactose (Renastart®) - low protein, low phosphorus, low potassium diet in infants and young children
  • ifosfamide (Holoxan®) - for the treatment of relapsed or refractory germ cell tumours or sarcomas
  • insulin neutral bovine (Hypurin Neutral®) and insulin isophane bovine (Hypurin Isophane®) - for the treatment of diabetes
  • candesartan (Auro-Candesartan 4®, Auro‑Candesartan 8®, Auro‑Candesartan 16®, Auro‑Candesartan 32®) - for the treatment of hypertension and heart failure
  • carbamazepine (Carbamazepine Sandoz®) - for the treatment of epilepsy, trigeminal neuralgia and mania and bipolar disorders
  • duloxetine (Duloxetine RBX®, Deotine 30®, Deotine 60®) - for the treatment of major depressive disorders
  • latanoprost (Latanoprost Actavis®) - for the treatment of glaucoma
  • macrogol-3350 + Sodium Chloride + Potassium Chloride + Bicarbonate (Lax-Sachets®) - for the treatment of constipation
  • metoprolol tartrate (Metatar®) - for the treatment of hypertension, angina and myocardial infarction
  • perindopril (Prexum 2.5®, Prexum 5®, Prexum 10®) - for the treatment of hypertension and heart failure
  • perindopril + indapamide (Prexum Combi 5/1.25®) - for the treatment of hypertension
  • roxithromycin (Roxithromycin GH®) - for the treatment of bacterial infections
  • acitretin (Neotigason®) - for the treatment of psoriasis
  • raloxifene (Evista®) - for the treatment of osteoporosis
  • ziprasidone (Zeldox®) - for the treatment of schizophrenia
  • Explanatory note for medicines that treat glaucoma - betaxolol (Betoptic S®, Betoptic®, BetoQuin®); bimatoprost (Lumigan®); bimatoprost + timolol (Ganfort 0.3/5®); brimonidine (Alphagan P 1.5®, Alphagan®, Enidin®); brimonidine + timolol (Combigan®); brinzolamide (Azopt®, BrinzoQuin®); brinzolamide + timolol (Azarga®); dorzolamide (Trusopt®); dorzolamide + timolol (Cosopt®); latanoprost (APO-Latanoprost®, Chem mart Latanoprost®, Latanoprost Pfizer®, Latanoprost Sandoz®, Terry White Chemists Latanoprost®, Xalatan®); latanoprost + timolol (Latanocom®, Xalacom®); pilocarpine (Isopto Carpine®); tafluprost (Saflutan®); timolol (Nyogel®, Tenopt®, Timoptol®, Timoptol XE®); timolol + travoprost (Duotrav®); travoprost (Travatan®)

All PBS listings and price changes are subject to final arrangements being met by the suppliers of the medicines.